Webcast Information

Improving Cell Line Selection: Reducing time to Clinic

Is the traditional 105 week or even shorter classical 40-week cell line production process becoming a thing of the past? Log in to view the latest free, on-demand webcast from BioProcess International and Lonza to find out how you can improve cell line selection and reduce the time to clinical outcomes for your organization.  

The latest in BioProcesses International’s free on-demand webcast series, Improving Cell Line Selection: Reducing time to Clinical delivers:

• A historical view of cell line constructions.
• Key aspects in developing a shorter process.
• Avoiding multiple cloning steps.
• Insights regarding faster process considerations, including cGMP material supply.

Join Dr. Andy Racher of Lonza Biopharmaceuticals as he discusses how the development of cell line construction has been dramatically reduced and just how using a faster process can benefit your organization and clinical outcomes.